Affordable Access

Hyponatremia in patients with nocturnal enuresis treated with DDAVP.

Authors
  • Robson, W L
  • Nørgaard, J P
  • Leung, A K
Type
Published Article
Journal
European journal of pediatrics
Publication Date
Nov 01, 1996
Volume
155
Issue
11
Pages
959–962
Identifiers
PMID: 8911897
Source
Medline
License
Unknown

Abstract

Hyponatremia is a potential adverse effect in patients with nocturnal enuresis who are treated with DDAVP. To prevent this adverse effect we recommend that the patients prescribed DDAVP for nocturnal enuresis should be counseled not to ingest more than 240 ml (8 ounces) of fluid on any night that DDAVP is administered.

Report this publication

Statistics

Seen <100 times